Last update 01 Nov 2024

EJR-876-35

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
PRL-3
Mechanism
PRL-3 inhibitors(protein tyrosine phosphatase 4A3 inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseHemic and Lymphatic Diseases+ [2]
Active Indication
LeukemiaOvarian CancerTriple Negative Breast Cancer
Inactive Indication-
Originator Organization
University of VirginiaUniversity of Virginia
Active Organization
University of VirginiaUniversity of VirginiaKevirx, Inc.Kevirx, Inc.
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with EJR-876-35
Login to view more data
100 Translational Medicine associated with EJR-876-35
Login to view more data
100 Patents (Medical) associated with EJR-876-35
Login to view more data
100 Deals associated with EJR-876-35
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
LeukemiaPreclinical-
Kevirx, Inc.Kevirx, Inc.
01 Jul 2021
LeukemiaPreclinical
US
Kevirx, Inc.Kevirx, Inc.
01 Jul 2021
LeukemiaPreclinical
US
University of VirginiaUniversity of Virginia
01 Jul 2021
Ovarian CancerPreclinical
US
University of VirginiaUniversity of Virginia
01 Jul 2021
Ovarian CancerPreclinical-
Kevirx, Inc.Kevirx, Inc.
01 Jul 2021
Ovarian CancerPreclinical
US
Kevirx, Inc.Kevirx, Inc.
01 Jul 2021
Triple Negative Breast CancerPreclinical
US
University of VirginiaUniversity of Virginia
01 Jul 2021
Triple Negative Breast CancerPreclinical-
Kevirx, Inc.Kevirx, Inc.
01 Jul 2021
Triple Negative Breast CancerPreclinical
US
Kevirx, Inc.Kevirx, Inc.
01 Jul 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free